These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6411138)

  • 1. Antipyrine metabolite kinetics in rats: studies on dose and time dependence.
    Rhodes JC; Houston JB
    Biopharm Drug Dispos; 1983; 4(2):125-35. PubMed ID: 6411138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats.
    Shaw PN; Tseti J; Warburton S; Adedoyin A; Houston JB
    Drug Metab Dispos; 1986; 14(2):271-6. PubMed ID: 2870906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal effects on antipyrine metabolite kinetics in Aroclor 1254-treated rats.
    Shaw PN; Houston JB
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):232-40. PubMed ID: 3087023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pregnenolone carbonitrile, promethazine and antipyrine pretreatment on antipyrine metabolite formation in rats.
    Shaw PN; Hall ST; Houston JB
    Xenobiotica; 1986 Dec; 16(12):1109-16. PubMed ID: 3798958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of antipyrine metabolite formation in rats in vivo.
    Rhodes JC; Hall ST; Houston JB
    Xenobiotica; 1984 Sep; 14(9):677-86. PubMed ID: 6516440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antipyrine breath test in the rat: a pharmacokinetic model.
    Lockwood GF; Chenery RJ; Oldham HG; Standring P; Norman SJ
    Eur J Drug Metab Pharmacokinet; 1988; 13(3):207-14. PubMed ID: 3149242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent pharmacokinetics of antipyrine in the rat.
    Pollack GM; Li RC; Shen DD
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):69-81. PubMed ID: 6729251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phenobarbital steady state levels on antipyrine clearance and distribution in the rat.
    Pei YY; Bialer M; Levy RH
    Biopharm Drug Dispos; 1986; 7(1):11-9. PubMed ID: 3955196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between antipyrine and aminopyrine.
    Vesell ES; Passananti GT; Hepner GW
    Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 14C-antipyrine in suspensions of isolated rat liver cells.
    Aarbakke J; Bessesen A; Morland J
    Acta Pharmacol Toxicol (Copenh); 1977 Sep; 41(3):225-34. PubMed ID: 578651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipyrine pharmacokinetics in the pregnant rat.
    Dean M; O'Donnell L; Penglis S; Stock B
    Drug Metab Dispos; 1980; 8(4):265-7. PubMed ID: 6105062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo.
    Teunissen MW; Joeres RP; Vermeulen NP; Breimer DD
    Xenobiotica; 1983 Apr; 13(4):223-31. PubMed ID: 6624137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.
    Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H
    J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
    Danhof M; Krom DP; Breimer DD
    Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct measurement of aminopyrine N-demethylase and antipyrine hydroxylase activities in a monolayer rat primary isolated hepatocyte system.
    Kotake AN
    Biochem Pharmacol; 1981 Sep; 30(17):2473-9. PubMed ID: 21043248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon reduces hepatic drug metabolism in vivo in mice.
    Taylor G; Marafino BJ; Moore JA; Gurley V; Blaschke TF
    Drug Metab Dispos; 1985; 13(4):459-63. PubMed ID: 2863111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.
    Boobis AR; Brodie MJ; Kahn GC; Toverud EL; Blair IA; Murray S; Davies DS
    Br J Clin Pharmacol; 1981 Dec; 12(6):771-7. PubMed ID: 7340879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of metronidazole and antipyrine in hepatocytes isolated from mouse and rat.
    Loft S; Poulsen HE
    Xenobiotica; 1990 Feb; 20(2):185-91. PubMed ID: 2333715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of ozone, cadmium chloride and carbon tetrachloride on [14C]antipyrine metabolism in conscious rats.
    Dutta S; Kamat M; Gole D
    J Appl Toxicol; 1987 Apr; 7(2):97-103. PubMed ID: 3624772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of whole-body irradiation on the half-life of antipyrine and on the microsomal enzyme system of rats. Correlation between in vivo and in vitro results.
    Thiriot C; Gaboriaud F; Bernard P
    Enzyme; 1983; 30(3):205-8. PubMed ID: 6354704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.